Astoria Portfolio Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
5,579
+7
| +0.1% | +$1.34K | 0.3% | 68 |
|
|
2025
Q1 | $987K | Sell |
5,572
-1,507
| -21% | -$267K | 0.34% | 74 |
|
|
2024
Q4 | $1.24M | Buy |
7,079
+45
| +0.6% | +$7.9K | 0.44% | 45 |
|
|
2024
Q3 | $1.37M | Buy |
7,034
+195
| +3% | +$37.9K | 0.47% | 37 |
|
|
2024
Q2 | $1.17M | Buy |
6,839
+574
| +9% | +$98.5K | 0.42% | 39 |
|
|
2024
Q1 | $1.01M | Buy |
6,265
+70
| +1% | +$11.3K | 0.39% | 48 |
|
|
2023
Q4 | $1.07M | Buy |
6,195
+1,156
| +23% | +$200K | 0.44% | 40 |
|
|
2023
Q3 | $732K | Sell |
5,039
-83
| -2% | -$12.1K | 0.35% | 53 |
|
|
2023
Q2 | $684K | Buy |
5,122
+547
| +12% | +$73.1K | 0.26% | 69 |
|
|
2023
Q1 | $731K | Sell |
4,575
-961
| -17% | -$154K | 0.31% | 59 |
|
|
2022
Q4 | $828K | Buy |
5,536
+954
| +21% | +$143K | 0.39% | 48 |
|
|
2022
Q3 | $615K | Buy |
4,582
+1,095
| +31% | +$147K | 0.42% | 58 |
|
|
2022
Q2 | $534K | Buy |
3,487
+381
| +12% | +$58.3K | 0.39% | 62 |
|
|
2022
Q1 | $503K | Buy |
3,106
+403
| +15% | +$65.3K | 0.39% | 60 |
|
|
2021
Q4 | $366K | Buy |
+2,703
| New | +$366K | 0.29% | 92 |
|